Edgewise Therapeutics's total assets for Q4 2025 were $552.60M, a decrease of -5.29% from the previous quarter. EWTX total liabilities were $30.35M for the fiscal quarter, a 22.27% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.